NextPlat (NASDAQ:NXPL) Releases Quarterly Earnings Results

NextPlat (NASDAQ:NXPL) posted its earnings results on Tuesday. The company reported ($0.24) earnings per share (EPS) for the quarter, FiscalAI reports. The company had revenue of $12.81 million for the quarter. NextPlat had a negative return on equity of 34.22% and a negative net margin of 14.58%.

Here are the key takeaways from NextPlat’s conference call:

• The company completed a reverse split to maintain its Nasdaq listing; management says it was necessary but acknowledges investor negativity despite stating NextPlat has ~$14 million in cash, no debt, and high insider ownership.
• Healthcare showed an early turnaround — 340B contract revenue rose 94% sequentially in Q4, medication fulfillment now exceeds 7,000 prescriptions/month, and a new HealthWarehouse partnership enables expansion from Florida to all 50 states.
• Management implemented >$2 million in annualized cost reductions and cut operating expenses ~25% (salaries down ~20%, professional fees down ~49%), ending the year with strong liquidity and expecting substantially reduced cash burn in 2026.
• Full-year revenue declined ~18% to ~$54 million (healthcare down to ~$40 million from $52M) and consolidated gross margin fell to ~20% from 26% in 2024, though management reports sequential margin improvement and expects gradual recovery in 2026.
• E-commerce remained a growth engine — revenue rose ~6% to ~$15 million, with record device sales, higher recurring airtime revenue, new distribution agreements, defense/NATO contracts, and launches on Mercado Libre in five South American countries.

NextPlat Stock Performance

Shares of NXPL stock traded down $0.10 on Tuesday, hitting $0.37. 692,428 shares of the stock were exchanged, compared to its average volume of 2,657,993. The firm’s 50 day moving average is $0.55 and its two-hundred day moving average is $0.66. NextPlat has a one year low of $0.34 and a one year high of $1.11. The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $10.04 million, a PE ratio of -1.24 and a beta of 1.26.

NextPlat shares are set to reverse split on the morning of Monday, April 6th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, April 5th.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, NextPlat presently has an average rating of “Sell”.

Hedge Funds Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Simplicity Wealth LLC acquired a new stake in shares of NextPlat Corp. (NASDAQ:NXPL) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor acquired 600,000 shares of the company’s stock, valued at approximately $497,000. Simplicity Wealth LLC owned about 2.31% of NextPlat at the end of the most recent quarter. Hedge funds and other institutional investors own 1.30% of the company’s stock.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.